Understanding the Future of CDP & Its Role in Society

9:00 am Coffee & Networking

9:50 am Chairs Opening Remarks

10:00 am How to Progress Access to Medical Cannabis in the UK

Sourcing, Extraction and Formulation of Cannabinoids

10:30 am Toward the Establishment of GMP Process: From Cannabis Extraction Methods to Nanotechnology-Based Formulations

  • Manuel de Pra Research & Development Coordinator, Entourage Phytolab

11:00 am Networking Break

11:30 am Opportunities & Challenges in Clinical Trials with Focus on Multiple Sclerosis

Linking Cannabinoids to their Therapeutic Potential while Collecting Data on Patient Effects/Outcomes in Both Clinical & Non-Clinical Settings

12:00 pm A Party of Three: The Intriguing Interplay Between Three Cannabinoids for the Treatment of Insomnia

12:30 pm Lunch & Networking Break

1:00 pm The Swiss Army Knife of Cannabis and Cannabinoid Drug Development

  • Joseph Morgan non-exclusive medical advisor , Parea Biosciences and Undoo.com

1:30 pm Discovery & Development of a Cannabinoid-Derived Therapeutic for Glioblastoma

2:00 pm The Future of Inhaled Cannabinoid-Based Medicine in Cancer: An Alternative Treatment to Improve Quality of Life and Pain Management in Advanced Cancer Patients?

  • Aurelia De Pauw Vice-President Clinical Programs/ Medical Affairs , Tetra Bio-Pharma

2:30 pm Break

3:30 pm Is the Future of Cannabinoid Pharmaceuticals and Nutraceuticals based on Phytocannabinoids, Synthetics or Augmented Multiple Compound Formulations?

  • Gavin Clark Managing Director, Delta Eight Pharmaceuticals


• Single-compound, augmented multiple compound or whole plant fullspectrum?
• Natural vs. synthetic

• How natural source Cannabinoids work to effectively treat:
• Pain and inflammation
• Muscle spasms and seizures
• Nausea and vomiting

Improving Target Identification & Advancing Drug Administration Technology for Improved Efficacy

4:00 pm Real-World Data on Medical Cannabis from Canada’s Clinical Leaders: Santé Cannabis

4:30 pm Drug Target Prediction and Development Using an Integrated Computational & High-Throughput Screening Approach

5:00 pm Cannabinoid-Related IP: Novelty in the Treasure Trove


  • Teaching plants to do new tricks
  • Navigating jurisdictional differences
  • Methods of use, methods of production, compositions and formulations

Click to see the Full Event Guide for more information

5:30 pm Chair’s Closing Remarks & End of Conference